Editas Medicine Inc. [NASDAQ: EDIT] traded at a high on 06/16/20, posting a 6.70 gain after which it closed the day’ session at $30.88. The results of the trading session contributed to over 1325516 shares changing hands. Over the past one week, the price volatility of Editas Medicine Inc. stands at 7.30% while the volatility over the past one month is 6.33%.
The market cap for EDIT stock reached $1.57 billion, with 54.59 million shares outstanding and 54.15 million shares in the current float. Compared to the average trading volume of 919.05K shares, EDIT reached a trading volume of 1325516 in the most recent trading day, which is why market watchdogs consider the stock to be active.
What do top market gurus say about Editas Medicine Inc. [EDIT]?
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for EDIT shares is $35.17 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on EDIT stock is a recommendation set at 2.40. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
Wells Fargo have made an estimate for Editas Medicine Inc. shares, keeping their opinion on the stock as Equal Weight, with their previous recommendation back on February 21, 2020. The new note on the price target was released on April 12, 2019, representing the official price target for Editas Medicine Inc. stock.
The Average True Range (ATR) for Editas Medicine Inc. is set at 1.88, with the Price to Sales ratio for EDIT stock in the period of the last 12 months amounting to 65.03. The Price to Book ratio for the last quarter was 7.18, with the Price to Cash per share for the same quarter was set at 8.14.
How has EDIT stock performed recently?
Editas Medicine Inc. [EDIT] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 15.18. With this latest performance, EDIT shares gained by 17.50% in over the last four-week period, additionally plugging by 3.28% over the last 6 months – not to mention a rise of 36.58% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for EDIT stock in for the last two-week period is set at 63.47, with the RSI for the last a single of trading hit 67.58, and the three-weeks RSI is set at 61.17 for Editas Medicine Inc. [EDIT]. The present Moving Average for the last 50 days of trading for this stock 25.52, while it was recorded at 27.86 for the last single week of trading, and 25.06 for the last 200 days.
Editas Medicine Inc. [EDIT]: Deeper insight into the fundamentals
Operating Margin for any stock indicates how profitable investing would be, and Editas Medicine Inc. [EDIT] shares currently have an operating margin of -686.39. Editas Medicine Inc.’s Net Margin is presently recorded at -651.43.
Return on Total Capital for EDIT is now -50.32, given the latest momentum, and Return on Invested Capital for the company is -48.26. Return on Equity for this stock declined to -53.65, with Return on Assets sitting at -28.79. When it comes to the capital structure of this company, Editas Medicine Inc. [EDIT] has a Total Debt to Total Equity ratio set at 11.08. Additionally, EDIT Total Debt to Total Capital is recorded at 9.98, with Total Debt to Total Assets ending up at 5.71. Long-Term Debt to Equity for the company is recorded at 8.87, with the Long-Term Debt to Total Capital now at 7.98.
Reflecting on the efficiency of the workforce at the company, Editas Medicine Inc. [EDIT] managed to generate an average of -$643,010 per employee. Receivables Turnover for the company is 91.66 with a Total Asset Turnover recorded at a value of 0.04.Editas Medicine Inc.’s liquidity data is similarly interesting compelling, with a Quick Ratio of 6.20 and a Current Ratio set at 6.20.
Earnings analysis for Editas Medicine Inc. [EDIT]
With the latest financial reports released by the company, Editas Medicine Inc. posted -0.82/share EPS, while the average EPS was predicted by analysts to be reported at -0.67/share.When compared, the two values demonstrate that the company fail the estimates by a Surprise Factor of -22.40%. The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for EDIT.
Insider trade positions for Editas Medicine Inc. [EDIT]
There are presently around $1,326 million, or 75.10% of EDIT stock, in the hands of institutional investors. The top three institutional holders of EDIT stocks are: ARK INVESTMENT MANAGEMENT LLC with ownership of 5,335,941, which is approximately 19.982% of the company’s market cap and around 0.20% of the total institutional ownership; NIKKO ASSET MANAGEMENT AMERICAS, INC., holding 5,107,677 shares of the stock with an approximate value of $147.82 million in EDIT stocks shares; and SUMITOMO MITSUI TRUST HOLDINGS, INC., currently with $147.82 million in EDIT stock with ownership of nearly 3.222% of the company’s market capitalization.
Positions in Editas Medicine Inc. stocks held by institutional investors increased at the end of May and at the time of the May reporting period, where 97 institutional holders increased their position in Editas Medicine Inc. [NASDAQ:EDIT] by around 3,519,634 shares. Additionally, 101 investors decreased positions by around 3,142,831 shares, while 51 investors held positions by with 39,147,913 shares. The mentioned changes placed institutional holdings at 45,810,378 shares, according to the latest SEC report filing. EDIT stock had 26 new institutional investments in for a total of 354,708 shares, while 52 institutional investors sold positions of 1,029,173 shares during the same period.